BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 29965975)

  • 21. Integrating Blood Collection within Household Surveys: Lessons Learned from Nesting a Measles and Rubella Serological Survey within a Post-Campaign Coverage Evaluation Survey in Southern Province, Zambia.
    Mutembo S; Carcelen A; Mwansa FD; Searle K; Wanyiri JW; Book C; Thuma PE; Moss WJ; Hayford K
    Am J Trop Med Hyg; 2018 Dec; 99(6):1639-1642. PubMed ID: 30277204
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Measles and rubella serosurvey identifies rubella immunity gap in young adults of childbearing age in Zambia: The added value of nesting a serological survey within a post-campaign coverage evaluation survey.
    Hayford K; Mutembo S; Carcelen A; Matakala HK; Munachoonga P; Winter A; Wanyiri JW; Searle K; Mwansa FD; Mwiche A; Phiri C; Book C; Thuma PE; Moss WJ
    Vaccine; 2019 Apr; 37(17):2387-2393. PubMed ID: 30905529
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Immunization Programme and Coverage against Measles and Rubella in Spain. Challenges for Achieving their Elimination].
    Limia Sánchez A; Molina Olivas M
    Rev Esp Salud Publica; 2015; 89(4):357-64. PubMed ID: 26580791
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Measles-rubella mass immunization campaign in Albania, November 2000.
    Bino S; Kakarriqi E; Xibinaku M; Ion-Nedelcu N; Bukli M; Emiroglu N; Uzicanin A
    J Infect Dis; 2003 May; 187 Suppl 1():S223-9. PubMed ID: 12721917
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Progress Toward Measles and Rubella Elimination - India, 2005-2021.
    Murugan R; VanderEnde K; Dhawan V; Haldar P; Chatterjee S; Sharma D; Dzeyie KA; Pattabhiramaiah SB; Khanal S; Sangal L; Bahl S; Tanwar SSS; Morales M; Kassem AM
    MMWR Morb Mortal Wkly Rep; 2022 Dec; 71(50):1569-1575. PubMed ID: 36520657
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Post-vaccination campaign coverage evaluation of oral cholera vaccine, oral polio vaccine and measles-rubella vaccine among Forcibly Displaced Myanmar Nationals in Bangladesh.
    Khan AI; Islam MT; Siddique SA; Ahmed S; Sheikh N; Siddik AU; Islam MS; Qadri F
    Hum Vaccin Immunother; 2019; 15(12):2882-2886. PubMed ID: 31441679
    [No Abstract]   [Full Text] [Related]  

  • 27. Evaluation of the measles, mumps and rubella vaccination catch-up campaign in England in 2013.
    Simone B; Balasegaram S; Gobin M; Anderson C; Charlett A; Coole L; Maguire H; Nichols T; Rawlings C; Ramsay M; Oliver I
    Vaccine; 2014 Aug; 32(36):4681-8. PubMed ID: 24996125
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progress towards elimination of measles in Kenya, 2003-2016.
    Kisangau N; Sergon K; Ibrahim Y; Yonga F; Langat D; Nzunza R; Borus P; Galgalo T; Lowther SA
    Pan Afr Med J; 2018; 31():65. PubMed ID: 31007812
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exploring landscape of measles vaccination coverage: A step towards measles elimination goal in India.
    Dhalaria P; Kumar P; Verma A; Priyadarshini P; Kumar Singh A; Tripathi B; Taneja G
    Vaccine; 2024 Jun; 42(17):3637-3646. PubMed ID: 38704248
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Progress Toward Measles and Rubella Elimination - Indonesia, 2013-2022.
    Chacko S; Kamal M; Hastuti EB; Mildya F; Kelyombar C; Voronika V; Yosephine P; Tandy G; Anisiska D; Karolina S; Dewi LA; Khanal S; Bahl S; Wijayanti F; Merrill RD; Hsu CH; Morales M
    MMWR Morb Mortal Wkly Rep; 2023 Oct; 72(42):1134-1139. PubMed ID: 37856681
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunization delivery in the second year of life in Ghana: the need for a multi-faceted approach.
    Nyaku M; Wardle M; Eng JV; Ametewee L; Bonsu G; Larbi Opare JK; Conklin L
    Pan Afr Med J; 2017; 27(Suppl 3):4. PubMed ID: 29296139
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [MR vaccine].
    Nakayama T
    Nihon Rinsho; 2011 Sep; 69(9):1573-8. PubMed ID: 21922755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progress in Italy in control and elimination of measles and congenital rubella.
    Bonanni P; Bechini A; Boccalini S; Peruzzi M; Tiscione E; Boncompagni G; Mannelli F; Salmaso S; Filia A; Ciofi degli Atti M
    Vaccine; 2007 Apr; 25(16):3105-10. PubMed ID: 17306425
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Local discrepancies in measles vaccination opportunities: results of population-based surveys in Sub-Saharan Africa.
    Grout L; Conan N; Juan Giner A; Hurtado N; Fermon F; N'Goran A; Grellety E; Minetti A; Porten K; Grais RF
    BMC Public Health; 2014 Feb; 14():193. PubMed ID: 24559281
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Implementation and evaluation of a measles/rubella vaccination campaign in a campus university in the UK following an outbreak of rubella.
    Stevenson J; Murdoch G; Riley A; Duncan B; McWhirter M; Christie P
    Epidemiol Infect; 1998 Aug; 121(1):157-64. PubMed ID: 9747767
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Measles containing vaccine coverage and factors associated with its uptake among children aged 24-59 months in Cherangany Sub County, Trans Nzoia County, Kenya.
    Mamuti S; Tabu C; Marete I; Opili D; Jalang'o R; Abade A
    PLoS One; 2022; 17(2):e0263780. PubMed ID: 35196355
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A review of measles control in Kenya, with focus on recent innovations.
    Manakongtreecheep K; Davis R
    Pan Afr Med J; 2017; 27(Suppl 3):15. PubMed ID: 29296150
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of nationwide supplementary immunization in Lao People's Democratic Republic: Population-based seroprevalence survey of anti-measles and anti-rubella IgG in children and adults, mathematical modelling and a stability testing of the vaccine.
    Hachiya M; Miyano S; Mori Y; Vynnycky E; Keungsaneth P; Vongphrachanh P; Xeuatvongsa A; Sisouk T; Som-Oulay V; Khamphaphongphane B; Sengkeopaseuth B; Pathammavong C; Phounphenghak K; Kitamura T; Takeda M; Komase K
    PLoS One; 2018; 13(3):e0194931. PubMed ID: 29596472
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors associated with non-uptake of measles-rubella vaccine second dose among children under five years in Mtwara district council, Tanzania, 2017.
    Magodi R; Mmbaga EJ; Massaga J; Lyimo D; Mphuru A; Abade A
    Pan Afr Med J; 2019; 33():67. PubMed ID: 31448029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Progress toward measles elimination in Romania after a mass vaccination campaign and implementation of enhanced measles surveillance.
    Pistol A; Hennessey K; Pitigoi D; Ion-Nedelcu N; Lupulescu E; Walls L; Bellini W; Strebel P
    J Infect Dis; 2003 May; 187 Suppl 1():S217-22. PubMed ID: 12721916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.